Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vibrio cholerae lipopolysaccharide is a large, amphiphilic molecule found on the outer membrane surface of the Gram-negative bacterium Vibrio cholerae. LPS is composed of three main structural domains: lipid A (the hydrophobic anchor and toxic component), the core oligosaccharide, and the highly variable O-antigen polysaccharide chain, which determines serogroup specificity. The lipid A component can be modified (for example, by acylation changes) to enhance resistance to cationic antimicrobial peptides such as polymyxin B and to modulate immune detection. Variation in the O-antigen structure underpins the more than 200 serogroups of V. cholerae, with O1 and O139 being the most clinically important, causing epidemic cholera. The LPS molecule is critical for virulence through biofilm formation, intestinal adherence, and immune evasion, and it serves as a major antigen for diagnosis and vaccine development. LPS can also act as a receptor for bacteriophage infection and as an adhesin aiding bacterial colonization. The endotoxic activity of the lipid A portion contributes to the inflammatory response and sepsis risk during severe infections.
Disruption of outer membrane by cationic peptides (e.g., polymyxin B binds to lipid A, causing membrane destabilization) Elicitation of host immune response as a pathogen-associated molecular pattern (PAMP)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae lipopolysaccharide (V. cholerae LPS).